Abstract

Our lab has previously demonstrated that a physiological concentration (1 nM) of estrogen (E2) can downregulate voltage‐gated, L‐type Ca2+ (VGCC) channels in coronary arteries. The distal ends of coronary arteries obtained from hearts of female pigs were sectioned into longitudinal strips and incubated for 24 hrs in 1 nM E2, EtOH, an estrogen receptor (ER) α/β antagonist (ICI 182,780), and a G protein‐coupled ER antagonist (GPER; G15). The arterial strips were homogenized for Western blot analysis using an antibody reactive to the VGCC alpha1C subunit and protein kinase Gα. Our preliminary results suggest that the E2 induced VGCC downregulation is mediated through ER α/β, and not GPER. Furthermore, ER activation by E2 in endothelium intact arteries have an increase in PKG expression (known to inhibit VGCCs), decrease in VGCC expression, and less coronary arterial reactivity. Overall, our results suggest that the classical ERs can be therapeutically targeted in women to reduce the density of VGCCs. Support: NCRR of the NIH, Grant #P20 RR‐16460 and the Arkansas SURF program.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.